2009
DOI: 10.1016/j.ejmech.2009.04.020
|View full text |Cite
|
Sign up to set email alerts
|

Novel modified steroid derivatives of androstanolone as chemotherapeutic anti-cancer agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
26
0
1

Year Published

2009
2009
2021
2021

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 83 publications
(27 citation statements)
references
References 20 publications
0
26
0
1
Order By: Relevance
“…In light of the above discoveries, and in continuation of studies involving the synthesis of novel biologically active modified steroids [9,12,13]. In the present study, some novel steroid hybrids incorporating the pyrrole or thiazole moiety through different linkages have been developed and it is expected to exhibit anti-inflammatory, anti-nociceptive, and/or non-ulcerogenic activities.…”
Section: Introductionmentioning
confidence: 97%
“…In light of the above discoveries, and in continuation of studies involving the synthesis of novel biologically active modified steroids [9,12,13]. In the present study, some novel steroid hybrids incorporating the pyrrole or thiazole moiety through different linkages have been developed and it is expected to exhibit anti-inflammatory, anti-nociceptive, and/or non-ulcerogenic activities.…”
Section: Introductionmentioning
confidence: 97%
“…This study motivated us to assemble newer and more widely effective kinase inhibitors. Our synthetic approach is based on the concept of molecular hybridization, an effective tool for the cogent design of novel molecular constructs by covalently conjugating two or more active pharmacophores [24]. Such constructs are known to exhibit improved pharmacokinetic-dynamic properties, potency to act on more than one target with reduced side effects and efficacy in case of drug resistant cases [25].…”
Section: Introductionmentioning
confidence: 99%
“…The clubbed pharmacophores may act on multiple therapeutic targets and offer the advantage of overcoming inevitable drug resistance [16]. In addition, the hybrids may also minimize unwanted side effects and allow for synergistic action [17]. The molecular hybrid approach has already been applied in developing novel antimalarial agents to overcome drug resistance [18].…”
Section: Introductionmentioning
confidence: 99%